How Theranos Hurt the Entire Medical Tech Industry

Medical Tech Industry

The medical field is no stranger to fraud. With so much money changing hands on a daily basis, there are bound to be a few individuals who try to take advantage of the situation.

But one of the most recent developments, involving more than $700 million and Elizabeth Holmes, founder of Theranos, is one of the most significant cases to date. It’s expected to have considerable fallout throughout the entire medical tech industry.

What Happened?

Medical Tech Industry

(Source: Wikipedia)

Founded by Holmes in 2003, Theranos quickly developed a reputation for their alternatives to traditional medical testing products. Although she was only 19 years old at the time, she quickly led her company to reach a height of $9 billion in market value.

But Theranos’ success was short-lived. A 2015 report, published in the Wall Street Journal, accused the young enterprise of misrepresenting their products. The expose shed light on their flawed technology and testing procedures, which ultimately resulted in Theranos voiding two years of blood samples.

The report unveiled another bombshell, too — the accusation that Holmes cheated on her required CLIA proficiency exams. Such discrepancies eventually led to new investigations by other media outlets, including the likes of The New Yorker, Fortune and The Financial Times, which uncovered further misdeeds.

She has since been charged with federal wire fraud and has resigned as the CEO of Theranos.

The iPod of Healthcare?

While fraud is rampant in some areas of medical tech, the field is often prone to errors — legitimate mistakes do occur. It’s been reported that 80 percent of all medical bills contain errors such as duplicate statements, incorrect patient or provider information, missing denial codes or claim numbers and more.

But Elizabeth Holmes made significant errors right from the start. While she was savvy enough to model her public image after Apple’s founder, Steve Jobs, she failed to mimic his business prowess.

Although she even went as far as adopting his signature black turtleneck for public appearances, she insisted on personally leading Theranos — which is something that Jobs never did with Apple.

She also failed to maintain a realistic vision for Theranos and their future products. Jobs succeeded because he understood the technology needed for devices like the iPod.

Although the technology existed, no one had ever assembled it in that way — and that’s really where Steve Jobs shined.

Instead, Holmes set her sights on brand new projects involving technology and methodologies that didn’t exist. She was trying to tread new ground in an area she didn’t fully understand or appreciate.

While she referred to a new blood testing product as the “iPod of healthcare,” she had no clear path of progression to reach that goal.

How Will This Affect Future Medical Tech Investments?

Holmes’ misrepresentation and subsequent misdoings have left a sour taste in the mouth of some investors. As pointed out by Michael Greeley, a general partner with Flare Capital Partners, investors are bound to lose faith in new medical tech.

As Greeley pointed out in a recent interview, dozens of investment firms were in medical tech a few short years ago. The number continues to drop significantly, and experts expect further disinterest. Although the situation is grim, Greeley stressed he cannot directly attribute this to Holmes or Theranos — yet.

Moving Forward

While breakthroughs like the Internet of Things (IoT), artificial intelligence (AI) and machine learning will continue to evolve and shape the technological development of the medical industry, there’s no telling how much this advancement will suffer because of the Theranos scandal.

It’s hard to imagine a scenario where investors pull out of medical tech entirely, but they’ll certainly think twice before putting their money on the line in the coming weeks, months and years.

By Kayla Matthews

Will Crump

The Key to a Successful M&A = Data

Successful M&A = Data Data is often the single point of failure for many organizations. Divestitures, privatization, leveraged buyouts, and management buyouts are all on the rise, but data too often remains an afterthought, rather ...
Kip Compton

What’s Ahead for Cloud

The Cloud 2018 was an incredible time for cloud. Its impact on customer experiences, business processes and models, and workforce innovations was undeniable. We saw more and more use cases where customers started leveraging multiple ...
Sebastian Grady

ERP Software License versus Cloud ERP SaaS Subscription ─ Pros and Cons 

Software License versus SaaS Subscription Your software is an asset. Software vendors such as Oracle and SAP are pressing customers to replace existing enterprise applications in order to move to the vendor’s new platform. Yet, ...
Patrick Joggerst

Payments Companies Will Always See ROI on Embedded Real Time Communications

ROI on Embedded Real Time Communications Without secure, real time communications applications, the financial services industry could literally come to a standstill. While transactions are driven by data, the human voice and human messaging continues ...
Alex Brisbourne

Industrial IoT Cyberattacks Continue To Rise

IoT Industrial Security The Internet of Things (IoT) includes both traditional electronics and everyday ‘things’ embedded with sensors, computing, and networking capabilities. From smart coffee makers and smart homes to smart lighting and smart cities, ...
Ramanan GV

Establishing a Unified Governance Model for the Digital Workforce

Increase visual control and reduce OPEX by 30% The Digital Service Providers (DSPs) are riding an automation wave. Painful manual tasks, which burdened staffs for ages, can now be easily handled by the software bots ...